Viridian Therapeutics Inc (NAS:VRDN)
$ 12.34 0.74 (6.38%) Market Cap: 787.57 Mil Enterprise Value: 347.92 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 46/100

Q4 2019 miRagen Therapeutics Inc Earnings Call Transcript

Mar 11, 2020 / 08:30PM GMT
Release Date Price: $9.18 (-8.44%)
Operator

Greetings. Welcome to Miragen Therapeutics Fourth Quarter 2019 Earnings Call. (Operator Instructions) Note, this conference is being recorded.

I will now turn the conference over to Dan Ferry with LifeSci Advisors. Thank you. You may begin.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator. Good afternoon, everyone, and welcome to our fourth quarter and year-end 2019 conference call. Today, after the market closed, we issued a press release regarding our financial results and corporate updates for the fourth quarter and full year 2019. A replay of today's call will be available on the Investors section of our website approximately 1 hour after its completion. After our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot